1.0 mg estradiol / 0.5 mg norethisterone acetate (NETA)

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

HealthyMenopause

Phase 1

Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women

CompletedNCT01477632

Novo Nordisk A/SHealthy, Menopause

Start: 2005-03-31End: 2005-06-30Updated: 2016-01-15

Phase 4

Bleeding Profile With Continuous Hormone Replacement Therapy of Activelle® in Postmenopausal Women

CompletedNCT01705249

Novo Nordisk A/SHealthy, Menopause

Start: 2001-08-14End: 2003-06-06Updated: 2017-02-28